Karuna Therapeutics
Why Robinhood?
You can watch KRTX and buy or sell other stocks, ETFs, and their options commission-free!About KRTX
Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA.
KRTX Key Statistics
Stock Snapshot
The current Karuna Therapeutics(KRTX) stock price is $329.83, with a market capitalization of 12.6B. The stock trades at a price-to-earnings (P/E) ratio of -28.13.
Karuna Therapeutics(KRTX) stock opened on 2026-07-16 at —. The price climbed to — and dipped to —.
The Karuna Therapeutics(KRTX)'s current trading volume is 0, compared to an average daily volume of 525.45K.
In the last year, Karuna Therapeutics(KRTX) shares hit a 52-week high of $329.99 and a 52-week low of $158.38.
In the last year, Karuna Therapeutics(KRTX) shares hit a 52-week high of $329.99 and a 52-week low of $158.38.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.